Sorted By:

Relevance


VIDEO: PhRMA CEO discusses industry response to opioid crisis on Mornings with Maria

PhRMA  |  Blog Post

   
http://catalyst.phrma.org/video-phrma-ceo-discusses-industry-response-to-opioid-crisis-on-mornings-with-maria

Las Compañías Biofarmacéuticas de Estados Unidos Lanzan una Innovadora Iniciativa Anunciando la Nueva Era de la Medicina

PhRMA  |  Press Release

Desde el año 2000, las empresas miembros de PhRMA han invertido más de medio trillón de dólares en la búsqueda de nuevos tratamientos y curas, incluyendo un estimado de $58.8 mil millones en el año 2015 por sí solo.
http://www.phrma.org/press-release/las-compa-as-biofarmac-uticas-de-estados-unidos-lanzan-una-innovadora-iniciativa-anunciando-la-nueva-era-de-la-medicina

PhRMA Statement on Support of DEA National Take Back Day

PhRMA  |  Press Release

PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines.
http://www.phrma.org/press-release/phrma-statement-on-support-of-dea-national-take-back-day

CEF

PhRMA  |  Company

...
http://www.phrma.org/company/cef

PhRMA CEO in Forbes - How to negotiate better deals for prescription medicines

PhRMA  |  Blog Post

Any discussion about value must include recognition of the shared responsibility to make sure patients actually get the medicines they need.
http://catalyst.phrma.org/phrma-ceo-in-forbes-how-to-negotiate-better-deals-for-prescription-medicines

Rare Disease Day: Accelerating innovation for patients in need

PhRMA  |  Blog Post

Learn more about progress in rare disease research here.
http://catalyst.phrma.org/rare-disease-day-accelerating-innovation-for-patients-in-need

World AIDS Day 2016: A decade of scientific innovation

PhRMA  |  Blog Post

Currently, 33 vaccine candidates are in clinical development, offering tremendous hope for a future without HIV/AIDS.
http://catalyst.phrma.org/world-aids-day-2016-a-decade-of-scientific-innovation

Celebrating hope for patients and families on World Heart Day 2016

PhRMA  |  Blog Post

World Heart Day is a reminder that innovation helps reduce the impact of heart disease on patients and families.
http://catalyst.phrma.org/celebrating-hope-for-patients-and-families-on-world-heart-day-2016

Medicare Monday: 3 reasons why repealing Part D’s noninterference clause is a bad idea

PhRMA  |  Blog Post

It’s important to find ways to build on Part D’s success, not undermine a program that over 40 million beneficiaries rely on for access to medicines.
http://catalyst.phrma.org/medicare-monday-3-reasons-why-repealing-part-ds-noninterference-clause-is-a-bad-idea

Un informe describe diversos medicamentos nuevos en desarrollo para combatir la epidemia de diabetes que afecta a más de 30 millones de estadounidenses

PhRMA  |  Press Release

Conéctese con PhRMAPara obtener información sobre cómo salvan vidas los medicamentos innovadores, por favor visite: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
http://www.phrma.org/press-release/medicamentos-en-desarrollo-para-la-diabetes

PhRMA Announces Support for Seven-Day Script Limit on Opioid Medicines for Acute Pain

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than $600 billion in the search for new treatments and cures, including an estimated $65.5 billion in 2016 alone.
http://www.phrma.org/press-release/phrma-announces-support-for-seven-day-script-limit-on-opioid-medicines-for-acute-pain

Reauthorize the Prescription Drug User Fee Act

PhRMA  |  Graphic

Reauthorization of the Prescription Drug, Biosimilar and Generic Drug User Fee Acts is crucial to ensuring innovative new medicines continue to reach patients in need.
http://www.phrma.org/graphic/reauthorize-the-prescription-drug-user-fee-act

Medicare Monday: Did you know … ?

PhRMA  |  Blog Post

For more videos on Part D, click .youtube.com/playlist?
http://catalyst.phrma.org/medicare-monday-did-you-know

Video: Translating science into new medicines

PhRMA  |  Blog Post

His personal experiences helping his father with diabetes and later his mother with metastatic breast cancer helped shape his passion for researching new treatments.
http://catalyst.phrma.org/video-translating-science-into-new-medicines

ICYMI: New era of medicine initiative kicks off in Boston

PhRMA  |  Blog Post

Ubl provides underwriter perspective on new era of medicine happening in science.
http://catalyst.phrma.org/icymi-new-era-of-medicine-initiative-kicks-off-in-boston

Medicare Monday: Kicking off 2017 with Medicare resources

PhRMA  |  Blog Post

Be sure to subscribe to the Catalyst.
http://catalyst.phrma.org/medicare-monday-kicking-off-2017-with-medicare-resources

PhRMA Lanza Nuevos Recursos del Cuidado de la Salud en Español

Access Better Coverage  |  From Our Network

Para obtener más recursos, visite www.AccessBetterCoverage.org/espanol.
http://www.accessbettercoverage.org/social-news/phrma-lanza-nuevos-recursos-del-cuidado-de-la-salud-en-espanol

Nuevos Informes Destacan el Aumento de la Competencia Global en I + D Biofarmacéutica, Planteando Desafíos Significativos para la Futura Posición de Estados Unidos

PhRMA  |  Press Release

Conectar con PhRMA Para obtener información sobre cómo los medicamentos innovadores salvan vidas, por favor visite: www.PhRMA.org .innovation.org/?
http://www.phrma.org

Statement on Biosimilar User Fee Act Reauthorization

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
http://www.phrma.org/press-release/statement-on-biosimilar-user-fee-act-reauthorization1

Las Compañías Miembros de PhRMA Invirtieron $58,8 Billones en I&D en 2015

PhRMA  |  Press Release

  Conectar con PhRMA Para obtener información sobre cómo los medicamentos innovadores salvan vidas, por favor visite:   www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
http://www.phrma.org/press-release/las-compa-as-miembros-de-phrma-invirtieron-58-8-billones-en-iandd-en-2015

ICYMI: Survey highlights key barriers limiting number and scale of new approaches to paying for medicines

PhRMA  |  Blog Post

Create a new safe harbor to the AKS to protect value-based arrangements and provide clarity for companies.
http://catalyst.phrma.org/icymi-survey-highlights-key-barriers-limiting-number-and-scale-of-new-approaches-to-paying-for-medicines

What's the deal with these prescription drug middlemen?

PhRMA  |  Video

Learn more about the conversation we're convening with the Let's Talk About Cost initiative. 
http://www.phrma.org/video/what-s-the-deal-with-these-prescription-drug-middlemen

Let's Talk About Cost

PhRMA  |  From PhRMA

View reports that explore the slowdown in medicine cost growth, the rising cost of chronic disease, insurance coverage of medicine, the role of middlemen, and what our industry can do to make medicine more affordable for patients....
http://www.phrma.org/media/let-s-talk-about-cost

How to get value assessment frameworks right

PhRMA  |  Blog Post

Read how value assessment frameworks fit within PhRMA’s pragmatic, patient-centric approaches to building a stronger U.S. health care market here.
http://catalyst.phrma.org/how-to-get-value-assessment-frameworks-right

Statement on Biosimilar User Fee Act Reauthorization

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.
http://www.phrma.org/press-release/statement-on-biosimilar-user-fee-act-reauthorization

You have reviewed the first 25 results out of 2064. Each page contains 25 results. You're on page 1.

prev 1 2 3 4 5 6 next